Involvement of Akt isoforms in chemoresistance of endometrial carcinoma cells

Gynecologic Oncology

Volumn 128, Issue 2, 2013, Pages 335-343

  Girouard, Julie ^a   Lafleur, Marie Judith ^a   Parent, Sophie ^a   Leblanc, Valérie ^a   Asselin, Eric ^a  

^a UNIVERSITÉ DU QUÉBEC À TROIS RIVIÈRES   (Canada)

Author keywords

Akt; Cisplatin; Endometrial cancer; PARP; Poly(ADP ribose) polymerase; Protein kinase B

Indexed keywords

AKT1 PROTEIN; AKT3 PROTEIN; CASPASE 3; CASPASE 6; CASPASE 9; CISPLATIN; DOXORUBICIN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PACLITAXEL; PROTEIN KINASE B; PROTEIN KINASE B BETA; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CELL MIGRATION; CELL MOTILITY; CELL PROLIFERATION; DOWN REGULATION; ENDOMETRIUM CARCINOMA; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; METASTASIS; MOLECULAR DYNAMICS; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; RNA INTERFERENCE; TUMOR GROWTH;

ANTIBIOTICS, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL LINE, TUMOR; CELL MOVEMENT; CISPLATIN; DOWN-REGULATION; DOXORUBICIN; DRUG RESISTANCE, NEOPLASM; ENDOMETRIAL NEOPLASMS; FEMALE; GENE KNOCKDOWN TECHNIQUES; HUMANS; ISOENZYMES; ONCOGENE PROTEIN V-AKT; PROTO-ONCOGENE PROTEINS C-AKT; RNA, SMALL INTERFERING; TRANSFECTION;

EID: 84872855144     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2012.11.016     Document Type: Article

References (30)

1. R. Siegel, E. Ward, O. Brawley, and A. Jemal Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths CA Cancer J Clin 61 2011 212 236
2. M.J. Arends, and A.H. Wyllie Apoptosis: mechanisms and roles in pathology Int Rev Exp Pathol 32 1991 223 254
3. S.R. Datta, A. Brunet, and M.E. Greenberg Cellular survival: a play in three Akts Genes Dev 13 1999 2905 2927
4. Y.R. Chin, and A. Toker Function of Akt/PKB signaling to cell motility, invasion and the tumor stroma in cancer Cell Signal 21 2009 470 476
5. K.M. Nicholson, and N.G. Anderson The protein kinase B/Akt signalling pathway in human malignancy Cell Signal 14 2002 381 395 (Pubitemid 34214843)
6. B. Vanhaesebroeck, and D.R. Alessi The PI3K-PDK1 connection: more than just a road to PKB Biochem J 346 Pt 3 2000 561 576 (Pubitemid 30171014)
7. W.S. Chen, P.Z. Xu, K. Gottlob, M.L. Chen, K. Sokol, and T. Shiyanova Growth retardation and increased apoptosis in mice with homozygous disruption of the Akt1 gene Genes Dev 15 2001 2203 2208 (Pubitemid 32843832)
8. H. Cho, J.L. Thorvaldsen, Q. Chu, F. Feng, and M.J. Birnbaum Akt1/PKBalpha is required for normal growth but dispensable for maintenance of glucose homeostasis in mice J Biol Chem 276 2001 38349 38352
9. H. Cho, J. Mu, J.K. Kim, J.L. Thorvaldsen, Q. Chu, and E.B. Crenshaw 3rd Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB beta) Science 292 2001 1728 1731 (Pubitemid 32506248)
10. R.M. Easton, H. Cho, K. Roovers, D.W. Shineman, M. Mizrahi, and M.S. Forman Role for Akt3/protein kinase Bgamma in attainment of normal brain size Mol Cell Biol 25 2005 1869 1878 (Pubitemid 40280150)
11. A. Bellacosa, C.C. Kumar, A. Di Cristofano, and J.R. Testa Activation of AKT kinases in cancer: implications for therapeutic targeting Adv Cancer Res 94 2005 29 86 (Pubitemid 41202364)
12. M. Sun, G. Wang, J.E. Paciga, R.I. Feldman, Z.Q. Yuan, and X.L. Ma AKT1/PKBalpha kinase is frequently elevated in human cancers and its constitutive activation is required for oncogenic transformation in NIH3T3 cells Am J Pathol 159 2001 431 437 (Pubitemid 32751073)
13. M. Sun, J.E. Paciga, R.I. Feldman, Z. Yuan, D. Coppola, and Y.Y. Lu Phosphatidylinositol-3-OH kinase (PI3K)/AKT2, activated in breast cancer, regulates and is induced by estrogen receptor alpha (ERalpha) via interaction between ERalpha and PI3K Cancer Res 61 2001 5985 5991 (Pubitemid 32762525)
14. Z.Q. Yuan, M. Sun, R.I. Feldman, G. Wang, X. Ma, and C. Jiang Frequent activation of AKT2 and induction of apoptosis by inhibition of phosphoinositide-3-OH kinase/Akt pathway in human ovarian cancer Oncogene 19 2000 2324 2330 (Pubitemid 30307208)
15. D.A. Altomare, S. Tanno, A. De Rienzo, A.J. Klein-Szanto, K.L. Skele, and J.P. Hoffman Frequent activation of AKT2 kinase in human pancreatic carcinomas J Cell Biochem 87 2002 470 476
16. M.J. Arboleda, J.F. Lyons, F.F. Kabbinavar, M.R. Bray, B.E. Snow, and R. Ayala Overexpression of AKT2/protein kinase Bbeta leads to up-regulation of beta1 integrins, increased invasion, and metastasis of human breast and ovarian cancer cells Cancer Res 63 2003 196 206 (Pubitemid 36070440)
17. K. Nakatani, D.A. Thompson, A. Barthel, H. Sakaue, W. Liu, and R.J. Weigel Up-regulation of Akt3 in estrogen receptor-deficient breast cancers and androgen-independent prostate cancer lines J Biol Chem 274 1999 21528 21532
18. V. Gagnon, I. Mathieu, E. Sexton, K. Leblanc, and E. Asselin AKT involvement in cisplatin chemoresistance of human uterine cancer cells Gynecol Oncol 94 2004 785 795 (Pubitemid 39194476)
19. V. Gagnon, C. Van Themsche, S. Turner, V. Leblanc, and E. Asselin Akt and XIAP regulate the sensitivity of human uterine cancer cells to cisplatin, doxorubicin and taxol Apoptosis 13 2008 259 271
20. P. Li, D. Nijhawan, I. Budihardjo, S.M. Srinivasula, M. Ahmad, and E.S. Alnemri Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade Cell 91 1997 479 489 (Pubitemid 27508237)
21. X. Yang, M. Fraser, U.M. Moll, A. Basak, and B.K. Tsang Akt-mediated cisplatin resistance in ovarian cancer: modulation of p53 action on caspase-dependent mitochondrial death pathway Cancer Res 66 2006 3126 3136
22. C. Alexia, M. Bras, G. Fallot, N. Vadrot, F. Daniel, and M. Lasfer Pleiotropic effects of PI-3′ kinase/Akt signaling in human hepatoma cell proliferation and drug-induced apoptosis Ann N Y Acad Sci 1090 2006 1 17 (Pubitemid 47092103)
23. M.W. Lee, D.S. Kim, J.H. Lee, B.S. Lee, S.H. Lee, and H.L. Jung Roles of AKT1 and AKT2 in non-small cell lung cancer cell survival, growth, and migration Cancer Sci 102 2011 1822 1828
24. A. Rouette, S. Parent, J. Girouard, V. Leblanc, and E. Asselin Cisplatin increases B-cell-lymphoma-2 expression via activation of protein kinase C and Akt2 in endometrial cancer cells Int J Cancer 130 2012 1755 1767
25. J.Q. Cheng, X. Jiang, M. Fraser, M. Li, H.C. Dan, and M. Sun Role of X-linked inhibitor of apoptosis protein in chemoresistance in ovarian cancer: possible involvement of the phosphoinositide-3 kinase/Akt pathway Drug Resist Updat 5 2002 131 146 (Pubitemid 35033805)
26. S.A. Santi, and H. Lee Ablation of Akt2 induces autophagy through cell cycle arrest, the downregulation of p70S6K, and the deregulation of mitochondria in MDA-MB231 cells PLoS One 6 2011 e14614
27. F. Un G1 arrest induction represents a critical determinant for cisplatin cytotoxicity in G1 checkpoint-retaining human cancers Anticancer Drugs 18 2007 411 417 (Pubitemid 46712404)
28. D.A. Gewirtz A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin Biochem Pharmacol 57 1999 727 741 (Pubitemid 29094544)
29. H. Mizutani, S. Tada-Oikawa, Y. Hiraku, M. Kojima, and S. Kawanishi Mechanism of apoptosis induced by doxorubicin through the generation of hydrogen peroxide Life Sci 76 2005 1439 1453 (Pubitemid 40164773)
30. P.B. Schiff, and S.B. Horwitz Taxol stabilizes microtubules in mouse fibroblast cells Proc Natl Acad Sci USA 77 1980 1561 1565 (Pubitemid 10073801)